236 related articles for article (PubMed ID: 17592773)
1. Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
Johnatty SE; Spurdle AB; Beesley J; Chen X; Hopper JL; Duffy DL; Chenevix-Trench G;
Breast Cancer Res Treat; 2008 May; 109(1):91-9. PubMed ID: 17592773
[TBL] [Abstract][Full Text] [Related]
2. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
3. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
[TBL] [Abstract][Full Text] [Related]
5. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50.
Wang-Gohrke S; Chang-Claude J; Becher H; Kieback DG; Runnebaum IB
Cancer Res; 2000 May; 60(9):2348-50. PubMed ID: 10811106
[TBL] [Abstract][Full Text] [Related]
7. Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
Pooley KA; Healey CS; Smith PL; Pharoah PD; Thompson D; Tee L; West J; Jordan C; Easton DF; Ponder BA; Dunning AM
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):675-82. PubMed ID: 16614108
[TBL] [Abstract][Full Text] [Related]
8. Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: a meta-analysis.
Yang DS; Sung HJ; Woo OH; Park KH; Woo SU; Kim AR; Lee ES; Lee JB; Kim YH; Kim JS; Seo JH
Cancer Genet Cytogenet; 2010 Jan; 196(2):194-7. PubMed ID: 20082859
[TBL] [Abstract][Full Text] [Related]
9. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.
McCullough ML; Stevens VL; Diver WR; Feigelson HS; Rodriguez C; Bostick RM; Thun MJ; Calle EE
Breast Cancer Res; 2007; 9(1):R9. PubMed ID: 17244366
[TBL] [Abstract][Full Text] [Related]
11. Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.
Wagner K; Hemminki K; Israelsson E; Grzybowska E; Klaes R; Chen B; Butkiewicz D; Pamula J; Pekala W; Försti A
Endocr Relat Cancer; 2005 Dec; 12(4):917-28. PubMed ID: 16322331
[TBL] [Abstract][Full Text] [Related]
12. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
[TBL] [Abstract][Full Text] [Related]
13. Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.
Romano A; Lindsey PJ; Fischer DC; Delvoux B; Paulussen AD; Janssen RG; Kieback DG
Gynecol Oncol; 2006 May; 101(2):287-95. PubMed ID: 16360811
[TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers.
Berchuck A; Schildkraut JM; Wenham RM; Calingaert B; Ali S; Henriott A; Halabi S; Rodriguez GC; Gertig D; Purdie DM; Kelemen L; Spurdle AB; Marks J; Chenevix-Trench G
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2141-7. PubMed ID: 15598772
[TBL] [Abstract][Full Text] [Related]
15. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.
De Vivo I; Hankinson SE; Colditz GA; Hunter DJ
Cancer Res; 2003 Sep; 63(17):5236-8. PubMed ID: 14500352
[TBL] [Abstract][Full Text] [Related]
16. Multiplex genotyping of 1107 SNPs from 232 candidate genes identified an association between IL1A polymorphism and breast cancer risk.
Han W; Kang SY; Kang D; Park SK; Lee JY; Kim H; Park AK; Noh DY
Oncol Rep; 2010 Mar; 23(3):763-9. PubMed ID: 20127018
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.
Försti A; Jin Q; Altieri A; Johansson R; Wagner K; Enquist K; Grzybowska E; Pamula J; Pekala W; Hallmans G; Lenner P; Hemminki K
Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
McKay JD; McCullough ML; Ziegler RG; Kraft P; Saltzman BS; Riboli E; Barricarte A; Berg CD; Bergland G; Bingham S; Brustad M; Bueno-de-Mesquita HB; Burdette L; Buring J; Calle EE; Chanock SJ; Clavel-Chapelon F; Cox DG; Dossus L; Feigelson HS; Haiman CA; Hankinson SE; Hoover RN; Hunter DJ; Husing A; Kaaks R; Kolonel LN; Le Marchand L; Linseisen J; McCarty CA; Overvad K; Panico S; Purdue MP; Stram DO; Stevens VL; Trichopoulos D; Willett WC; Yuenger J; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):297-305. PubMed ID: 19124512
[TBL] [Abstract][Full Text] [Related]
19. GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism.
Huggins GS; Wong JY; Hankinson SE; De Vivo I
Cancer Res; 2006 Feb; 66(3):1384-90. PubMed ID: 16452193
[TBL] [Abstract][Full Text] [Related]
20. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
Zubor P; Kajo K; Stanclova A; Szunyogh N; Galo S; Dussan CA; Minarik G; Visnovsky J; Danko J
Eur J Cancer Prev; 2008 Feb; 17(1):33-8. PubMed ID: 18090908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
